Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib is being tested for safety and effectiveness in young children with severe alopecia areata.

Tofacitinib is a promising treatment for children with rheumatic diseases.

Ritlecitinib provides new treatment options for diverse alopecia areata patients.

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.

Using three different drugs together may better treat eye diseases like glaucoma and macular degeneration.

Ritlecitinib improves hair regrowth satisfaction in alopecia areata patients.

Ritlecitinib is more effective and cheaper than baricitinib for treating severe alopecia areata.

Methods accurately measure tamsulosin hydrochloride and finasteride in combined dosages.

Ritlecitinib 50 mg effectively promotes and sustains hair regrowth in alopecia areata patients.

Methotrexate dose has little effect on its toxicity when used with adalimumab for early rheumatoid arthritis.

Torilin from Torilis japonica can inhibit testosterone 5α-reductase but is less effective than finasteride.

Teriflunomide effectively reduces relapse rates and disease progression in multiple sclerosis but is not safe for use during pregnancy.

Ritlecitinib may cause serious side effects like blood clots in alopecia areata patients.

Ritlecitinib helped most alopecia areata patients regrow hair by Week 48.

Teriflunomide is effective and generally safe for treating relapsing multiple sclerosis, reducing relapse rates and disability progression.

Oral tofacitinib effectively treats alopecia areata long-term with manageable side effects.

Method accurately measures finasteride and tamsulosin in combined drug form.

Double pulse dose terbinafine effectively treats kerion type of tinea capitis.

Tavaborole is a safe and effective toenail fungus treatment, with the 5% solution being the best option.

Rizatriptan benzoate-loaded dissolving microneedles are effective and convenient for treating acute migraines.

A new method allows for controlled, long-lasting delivery of retinoic acid through the skin with fewer side effects.

The FDA approved Litfulo® for treating severe alopecia areata in people aged 12 and older.

CTP-543 effectively promotes hair regrowth in adults with moderate to severe alopecia areata.

Ritlecitinib effectively reduces severe hair loss in alopecia areata over 24 months.

Ritlecitinib is effective for long-term treatment of severe alopecia areata.

Ritlecitinib works well and is safe for treating alopecia areata.

Tridax procumbens may be a safe, affordable treatment for some health issues.

Ritlecitinib is the first FDA-approved pill for treating significant hair loss in alopecia areata patients aged 12 and up.